We invite you to register in the webinar “Nutraceuticals and M&A”
Nutraceuticals comprise a wide range of substances and foods which, in addition to their nutritional value, also offer medical or health benefits for the prevention and treatment of diseases. Due to the recent boom in consumer demand, nutraceuticals are experiencing a great deal of interest from investors, international pharmaceutical and food companies as well as mid-sized food ingredient and pharma companies in the areas of operations and investments / M&A.
The question is whether this trend – both in terms of market growth and investment interest – will continue, or if factors such as a waning pandemic, a looming recession, inflation and global supply chain issues will have a negative impact on supply, demand and thus, the overall attractiveness of the nutraceuticals market?
Our colleague Gonzalo Tobaruela, Corporate Development Director of SUANFARMA, will participate in the webinar “Nutraceuticals and Mergers & Acquisitions” together with other selected industry representatives.
AGENDA
- 10:00-10:20 am Nutraceuticals – Current Trends and M&A landscape
- Alexander Wenzel, Partner, Ebner Stolz
- Pranshu Rohatgi, Senior Manager, Ebner Stolz
- 10:20-11:00 am Nutraceuticals – Trends and Perspectives from Big Pharma
- Lucas Martin, Head of Business Development & Licensing Consumer Health EMEA, Bayer
- Felix von Berg, Senior Vice President, Global M&A, Stada
- 11:00-11:30 am Panel Discussion
- Gonzalo Tobaruela, Director, Corporate Development, SuanFarma
- Felix von Berg, Senior Vice President, Global M&A, Stada
- Lucas Martin, Head of Business Development & Licensing Consumer Health EMEA, Bayer
Please register here: https://register.gotowebinar.com/register/8824945732735145487